Programming - BCVS Scientific Sessions 2021

About this Meeting

The 16th annual BCVS 2021 Scientific Sessions has become the premier conference for molecular cardiovascular biology and disease. Sponsored by the American Heart Association Basic Cardiovascular Sciences Council, the world’s leading organization of cardiovascular scientists, the conference attracts leading researchers in fields such as microRNAs, cardiac gene and cell therapy, cardiac development and most recently tissue engineering and iPS cells.

Target Audience

  • Basic cardiovascular scientists
  • Molecular/cellular biologists
  • Physiologists
  • Translational investigators
  • Clinical trialists
  • Practicing cardiologists
  • Cardiovascular nurses and pharmacists

Learning Objectives

At the conclusion of the conference, participants will be able to:

  • Understand new developments in cardiovascular pathophysiology and implications for future therapeutics.
  • Discuss the lasted research on cardiovascular inflammation and how this links to heart failure.
  • Describe current knowledge gaps in research and understanding of cardiovascular disease.
  • Recognize the basis of cardio-immunology and the link to cardio-oncology.
  • Explain the potential role of and challenges involved in the use of big data analytics in precision medicine to guide treatment in cardiovascular disease including COVID-19 related injury.

BCVS 2021 Program Committee Members

Pilar Alcaide, MS, PhD, FAHA

Pilar Alcaide, MS, PhD, FAHA
Program Committee Chair
Tufts University School of Medicine

Sumanth Prabhu, MD, FAHA

Sumanth Prabhu, MD, FAHA
Program Committee Vice-Chair
University of Alabama at Birmingham


  • John Calvert, PhD, Emory University School of Medicine
  • Stefanie Dimmeler, PhD, Institute of Cardiovascular Regeneration Frankfurt
  • Aikaterini Kontrogianni Konstan, PhD, University of Maryland Medicine
  • Nicole Purcell, PhD, Huntington Medical Research Institute
  • Gangjian Qin, MD, PhD, University of Alabama at Birmingham
  • Hesham Sadek, MD, PhD, UT Southwestern Medical Center
  • Farah Sheikh, PhD, University of California San Diego
  • Akl Fahed, MD, MPH, Massachusetts General Hospital

Program Committee Disclosures (PDF)

2021 Preliminary Program

This section will be updated as speakers and presentations are confirmed. For a printable document, see the 2021 Schedule at a Glance (PDF)


Time (all times are Central)
11:00 - 11:15 a.m.

Early Career Opening Remarks

11:15 a.m. - 12:15 p.m.

Early Career Session 1: Next Best Thing in Cardiovascular Research

12:15 - 12:30 p.m.


12:30 - 1:15 p.m.

Early Career Session 2: Next Best Thing in Cardiovascular Research

1:15 - 1:45 p.m.

Early Career Keynote

1:45 - 2:00 p.m.


2:00 - 2:15 p.m.

Session 1: BCVS 2021 Opening Welcome

2:15 - 3:15 p.m.

Session 2A: Sarcomeric Cardiomyopathies: from Bedside to Bench and Back

Session 2B: Cardiac Repair and Tissue Engineering

3:15 - 3:30 p.m.


3:30 - 4:30 p.m.

Moderated Poster Session 1A

Moderated Poster Session 1B

4:30 - 5:30 p.m.

Session 3A: Small RNAs, Exosomes and Extracellular Vesicles in Cardiovascular Disease

Session 3B: Cellular Reprogramming in Heart Failure


Time (all times are Central)
10:00 - 11:00 a.m.

Session 4: Women in Science Breakfast

11:00 a.m. - Noon

Session 5: Keynote Speaker

Noon - 12:30 p.m.


12:30 - 1:30 p.m.

Session 6A: COVID-19 and Myocardial Injury: Short- and Long-Term Cardiovascular Effects

Session 6B: Novel Disease Pathways in Cardiac Remodeling

1:30 - 2:30 p.m.

Moderated Poster Session 2A

Moderated Poster Session 2B

2:30 - 2:45 p.m.


2:45 - 3:45 p.m.

Session 7: Outstanding Early Career Investigator Award Competition

3:45 - 4:00 p.m.


4:00 - 5:00 p.m.

BCVS Mix & Mingle – Sponsored by Early Career Committee


Time (all times are Central)
10:00 - 11:00 a.m.

Session 8A: Bench to Bedside: Cardiovascular Disease Therapies Not Lost in Translation

Session 8B: Deconstructing the Heart with Multiscale Approaches

11:00 a.m. - Noon

Session 9A: HFpEF and HFrEF Heterogeneity and Precision Medicine

Session 9B: Cardiotoxicity of Cancer Therapeutics: Cardio-oncology Meets Immunology

Noon - 12:30 p.m.


12:30 - 1:30 p.m.

Moderated Poster Session 3A

Moderated Poster Session 3B

1:30 - 2:30 p.m.

Session 10A: Myocytes and Non- myocytes in Cardiac Hypertrophy

Session 10B: State of the Art: New insights in Cardiac Fibrosis and Inflammation

2:30 - 2:45 p.m.

Closing Address